Percheron Therapeutics LimitedASX: PER

Dosing commenced in MCRI collaboration animal study

Feb 8, 2022 at 3:52 AM UTC · Issued by Percheron Therapeutics Limited

Percheron Therapeutics Limited has released a press release.

View Attachment